Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify or Tylenol autism cases. Thank you.
Select Page
Xarelto Litigation Heads to Trial

Xarelto Litigation Heads to Trial

The U.S. District Judge Eldon E. Fallon overseeing more than 18,000 Xarelto lawsuits ordered that hundreds of those cases be prepared for two waves as the blood thinner litigation heads to trial. Each wave will have 600 lawsuits. The Plaintiffs Steering Committee,...
Aspirin As Effective As Xarelto For Post-Surgical Bleeds

Aspirin As Effective As Xarelto For Post-Surgical Bleeds

Researchers studying the effects of Xarelto and aspirin use post surgery found no notable difference in post-surgical bleeds between the two. In fact, the only difference between Xarelto and aspirin is cost. Consumers pay around $425 a month for Xarelto compared to a...
Xarelto Still Without an Antidote

Xarelto Still Without an Antidote

FDA announced that Bayer’s popular blood thinner, Xarelto, will still not have an approved antidote. The government agency will not approve the antidote, AndexXa, without additional information from the manufacturer, Portola. This pushes back the possible approval...
Jury Orders $27.8M in Damages in Xarelto Trial

Jury Orders $27.8M in Damages in Xarelto Trial

In the first plaintiff win, a jury orders Xarelto manufacturers Johnson & Johnson and Bayer to pay $27.8 million in damages. The manufacturers won the first three cases in Louisiana and Mississippi, however, this shows that justice does eventually prevail.  ...
×
What Our Clients Are Saying